| Literature DB >> 26784244 |
Abstract
Heterochrony is an enabling concept in evolution theory that metaphorically captures the mechanism of biologic change due to mechanisms of growth and development. The spatio-temporal patterns of morphogenesis are determined by cell-to-cell signaling mediated by specific soluble growth factors and their cognate receptors on nearby cells of different germline origins. Subsequently, down-stream production of second messengers generates patterns of form and function. Environmental upheavals such as Romer's hypothesized drying up of bodies of water globally caused the vertebrate water-land transition. That transition caused physiologic stress, modifying cell-cell signaling to generate terrestrial adaptations of the skeleton, lung, skin, kidney and brain. These tissue-specific remodeling events occurred as a result of the duplication of the Parathyroid Hormone-related Protein Receptor (PTHrPR) gene, expressed in mesodermal fibroblasts in close proximity to ubiquitously expressed endodermal PTHrP, amplifying this signaling pathway. Examples of how and why PTHrPR amplification affected the ontogeny, phylogeny, physiology and pathophysiology of the lung are used to substantiate and further our understanding through insights to the heterochronic mechanisms of evolution, such as the fish swim bladder evolving into the vertebrate lung, interrelated by such functional homologies as surfactant and mechanotransduction. Instead of the conventional description of this phenomenon, lung evolution can now be understood as adaptive changes in the cellular-molecular signaling mechanisms underlying its ontogeny and phylogeny.Entities:
Keywords: cell-cell signaling; diachronic; evolution; growth factor; growth factor receptor; heterochrony; synchronic
Year: 2016 PMID: 26784244 PMCID: PMC4810161 DOI: 10.3390/biology5010004
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Background and significance for the reinterpretation of heterochrony.
The concept of heterochrony was first introduced by Ernst Haeckel in 1875 as the mechanistic basis for his Biogenetic Law. |
Heterochrony is due to a change in function or form during development. |
Kolman (1885) used the term paedomorphosis to describe heterochrony as process for retaining juvenile properties. |
De Beer (1930) used the term neoteny as a subcategory of heterochrony to describe the retention of earlier developmental properties. |
Peramorphosis is used to describe delayed maturation and extended periods of growth. |
In his book “Ontogeny and Phylogeny”, Stephen J. Gould described the significance and importance of heterochrony as the mechanism of evolution. However, he never provided a specific mechanism for how and why such changes occur, obviating the possibility of scientifically testing its hypothesized role in evolution. |
Since the late 1970s, the determination of growth and differentiation by soluble growth factor-mediated cell-cell signaling has been acknowledged to be the mechanism of development. |
Despite this, the advent of Evolutionary Developmental Biology, or EvoDevo has not assimilated growth factor signaling into its analyses. |
The current article demonstrates the value added in understanding heterochrony as a sequence of cell-cell interactions that can be modified by environmental factors to understand how and why evolution has occurred. The power of this approach is in its ability to understand the processes of development, physiology, homeostasis and pathology as one continuous, scale free evolutionary mechanism for the first time. |
This explanation of heterochrony offers a change in the language of evolutionary biology, representing what Kuhn [ |
Figure 1Active recruitment of neutral lipid from lipofibroblasts by alveolar Type II cells. Neutral lipids stored in lipofibroblasts are actively “trafficked” to alveolar Type II cells by means of Adipocyte Differentiation Related Protein (ADRP), regulated by Parathyroid Hormone-related Protein (PTHrP) produced by Type II cells. The Type II cells secrete Prostaglandin E2, stimulating the secretion of the neutral lipids, and the uptake of the neutral lipid by the Type II cells is regulated by leptin produced by the lipofibroblasts. Each of these steps is coordinately stretch-regulated to increase surfactant phospholipid synthesis by the Type II cell. The net result is surfactant phospholipid production integrated with the distension of the alveolar wall during breathing.
Figure 2Pathways for the developmental and phyletic evolution of lipofibroblast-Type II cell interactions. Extrinsic selection pressures are shown in italics; intrinsic selection pressures are shown in bold. (1) AMPs = Antimicrobial Peptides; (2) VDR = Vitamin D Receptor; (3) Type IV col = Type IV collagen ; (4) GR = Glucocorticoid Receptor; (5) 11βHSD = 11beta Hydroxysteroid Dehydrogenase; (6) βAR = beta Adrenergic Receptor; (7) ADRP = Adipocyte Differentiation Related Protein; (8) Leptin = Leptin; (9) Leptin R = Leptin Receptor; (10) PTHrP = Parathyroid Hormone-related Protein; (11) SP-B = Surfactant Protein-B. These changes in genetic expression were sequentially brought about by such environmental factors as salinity, water-land transition and fluctuations in atmospheric oxygen tension over the last 500 million years.